Canaccord Genuity Assumes Rhythm Pharmaceuticals (RYTM) at Buy
Tweet Send to a Friend
(Updated - January 18, 2023 7:14 AM EST)
Canaccord Genuity analyst Whitney Ijem assumes coverage on Rhythm Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Whitney Ijem assumes coverage on Rhythm Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
